Home/Filings/4/0001140361-18-044723
4//SEC Filing

Maxwell John T. 4

Accession 0001140361-18-044723

CIK 0001398733other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 4:27 PM ET

Size

4.3 KB

Accession

0001140361-18-044723

Insider Transaction Report

Form 4
Period: 2018-12-06
Maxwell John T.
SVP-Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-12-06$8.87/sh+5,000$44,350153,614 total
Footnotes (1)
  • [F1]Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.

Issuer

Aquestive Therapeutics, Inc.

CIK 0001398733

Entity typeother

Related Parties

1
  • filerCIK 0001739025

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 4:27 PM ET
Size
4.3 KB